Wegovy Here, Ozempic Next: Big Focus On India's Obesity & Diabetes Crisis, Says Novo's Cai
Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India 'as soon as possible", Dr Yan Cai, senior vice president of clinical development, medical affairs, and regulatory affairs for international operations, told News18.
Reaffirming the Danish drugmaker's commitment, she noted that India is among the top three countries globally in terms of both obesity and type 2 diabetes prevalence, making it a high-priority market.
'I can reassure that India is a very important market for us. With a large population living with type 2 diabetes, we are committed to bringing Ozempic to India. Wegovy and Ozempic serve different populations—Ozempic is for managing diabetes, while Wegovy is for weight loss," Dr Cai told News18 in an exclusive interaction. When asked about the timelines planned for the launch of Ozempic, she said, 'as soon as possible… it is our commitment."
Ozempic, originally developed for type 2 diabetes, shot to global fame as a weight loss sensation—fuelled by Hollywood celebrity endorsements and off-label use. Its surging demand has made it one of the world's best-selling drugs, breaking revenue records and reshaping the global obesity and diabetes treatment market.
Talking about the relevance of Wegovy for the Indian market, Cai said, India ranks third globally—after the US and China—in obesity prevalence, with over 200 million people estimated to be obese. 'It is also among the top two countries in terms of type 2 diabetes cases. The magnitude of these conditions is huge. We will continue to offer innovative treatments to help people live healthier lives," she said.
According to Dr Cai, Wegovy has proven clinical evidence showing it reduces risks related to heart disease, including stroke and myocardial infarction. 'It is the only anti-obesity drug that provides both weight loss and cardiovascular benefits. For people living with obesity or overweight—and especially those with a history of cardiovascular disease—it offers protective benefits," she said.
Wegovy is based on semaglutide, the same molecule used in Ozempic. Dr Cai explained that the molecule has a long history and has been used by over 33 million people worldwide.
'Semaglutide has been tried and trusted over the years in terms of safety. Its profile is well understood," she added.
She said Novo Nordisk has been a pioneer in the field of obesity treatment, having started research over 25 years ago. 'With Wegovy now launched and Ozempic in the pipeline, the company sees India as a core focus for future medical innovation."
'We will continue to provide treatments that make a meaningful difference. The scale of obesity and diabetes in India calls for urgent and sustained efforts—and we're committed to being part of the solution."
How Wegovy works—The science and the journey
Semaglutide is part of a drug class known as GLP-1 receptor agonists. It works by acting on receptors in the brain to suppress appetite, particularly the desire for fatty food. 'We have solid data from both human and animal studies showing reduced cravings. People feel full earlier, eat less, and some patients also tell us that they start choosing healthier foods—like salads—on their own," said Cai. 'It's not just about 'eat less, walk more.' Obesity is a complex disease that needs to be managed holistically—with medication, lifestyle changes, exercise, and an overall support system."
She emphasised that Wegovy helps balance energy intake and expenditure. 'It helps control cravings and hunger. People respond differently—some experience rapid weight loss, while others lose weight more gradually."
Journey of a patient on Wegovy
Starting Wegovy requires a careful dose titration process. Patients typically begin on a low dose, which is gradually increased every four weeks under medical supervision.
Some individuals may experience gastrointestinal side effects, such as nausea, especially in the early weeks. 'These side effects are usually mild and transient, and they are a natural reaction to this drug class. Around 50–60% of patients don't experience any symptoms at all," Cai noted. 'Most important is not to drop off too soon. The body adjusts over time."
Patients are advised to stay at the same dose for four weeks to allow their body to adapt. Based on Novo Nordisk's data and Dr Cai's own experience, 50% of patients stay at 1.7 mg, while 20–30% titrate up to 2.4 mg, which is the highest dose.
'Cardiovascular benefits kick in at higher doses. My advice is to work with your doctor to find the right dose and continue long enough to receive the full benefit. Cardiovascular improvements can be seen as early as 20 days into treatment, with more visible weight loss beginning around 12 to 16 weeks."
In clinical studies, 80–90% of patients achieved clinically significant weight loss, defined as more than 5% of body weight. 'More impressively, over 30% of patients lost more than 20% of their body weight within 6 to 8 months of starting treatment."
Is this the right price for Indian market?
Wegovy is currently priced between Rs 17,000 and Rs 26,000 per month for five doses.
Replying to the question on affordability and price-sensitive Indian consumers, Cai said, 'Novo Nordisk has introduced an India-specific pricing model to make the drug more accessible."
top videos
View all
'We have ensured that the first three dosing categories are priced the same, so patients don't face financial hurdles early in their treatment. This allows them to sustain the therapy without additional burden," Cai explained.
She added that Novo Nordisk is also developing new innovations to target different segments of patients in India, with future drugs to be priced accordingly, hinting that those who cannot afford this treatment can expect other new-age drugs from the company's portfolio in the coming years.
Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated!
tags :
diabetes health Obesity Weight Loss
Location :
New Delhi, India, India
First Published:
July 05, 2025, 08:00 IST
News india Wegovy Here, Ozempic Next: Big Focus On India's Obesity & Diabetes Crisis, Says Novo's Cai | Exclusive
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
Infosys HR sends 'detailed warning email' to employees: We must work….'
India's second-largest IT services company Infosys has begun sending personalized warning emails to employees who exceed standard working hours, directly contradicting founder N.R. Narayana Murthy 's recent advocacy for a 70-hour workweek. The Bengaluru-based firm has implemented an automated monitoring system that triggers alerts when employees work beyond 9 hours and 15 minutes daily. "We must work for 9.15 hours a day for five days a week, and if we overshoot this while working remotely, it prompts a trigger," an employee told The Economic Times. The company's HR department now tracks remote working hours monthly, sending detailed notifications to staff members who exceed prescribed durations. Infosys monitors remote work hours to prevent burnout The monitoring system was introduced following hybrid working arrangements for Infosys's 323,500 employees. When excessive hours are detected, HR sends comprehensive notifications including information about remote working days, total hours worked, and daily averages. The company's workplace policy, implemented in November 2023, requires staff to be present in office for minimum 10 days monthly. "While we appreciate your commitment, we also believe that maintaining a healthy work-life balance is crucial for both your well-being and long-term professional success," states the HR communication reviewed by financial dailies. The emails emphasize that prioritizing health and work-life balance benefits both personal wellbeing and professional success. Health concerns drive policy shift in Indian IT sector This initiative emerges amid growing concerns about young tech professionals facing health challenges, particularly cardiac issues attributed to irregular dietary and rest patterns. The company's guidance includes specific recommendations: "Take regular breaks during your workday; Let your manager know if you are feeling overwhelmed or need support with reviewing priorities." The policy represents a significant departure from Murthy's recent statements calling for Indians to work 70 hours weekly to accelerate economic growth. The move reflects evolving workplace norms in Indian IT, where employee mental health and sustainable productivity are gaining prominence over extended working hours.
News18
32 minutes ago
- News18
‘India's Criminal Justice System Reformatory, Not Retributive': Justice Surya Kant
Last Updated: Justice Surya Kant highlighted that while public perception seems to believe that addiction is simply a 'bad habit', it is a complex condition that alters a person's behaviour The Indian criminal justice system is reformatory, not retributive, said Justice Surya Kant on Friday at an event in Telangana. 'The school of thought followed by the Indian criminal justice system is reformatory, not retributive. We firmly believe in giving people a second chance, and we do not punish them simply for the sake of punishment," said Justice Kant, while inaugurating a dedicated de-addiction centre at Chanchalguda Central Prison, Hyderabad. The centre marks a significant step toward reforming lives within the prison system. With a focus on holistic recovery, the centre aims to provide medical treatment, psychological counselling, and rehabilitative support to inmates affected by substance abuse. As emphasised during the event, addiction is not merely a bad habit—it is a condition that requires care, understanding, and sustained support. Speaking further, Justice Surya Kant highlighted that while the public perception seems to believe that addiction is simply a 'bad habit', it is a serious and complex condition that alters a person's behaviour, their thinking, their emotions, and their control over their actions. 'Addiction to any substance can lead even the best person astray and compel them to make bad choices," he added.
India Today
39 minutes ago
- India Today
Brown rice vs white rice: Understanding the nutritional and health benefits
Brown rice has gained popularity as a healthier alternative to white rice, and science backs this claim. Both types of rice originate from the same grain, but the way they are processed has a dramatic impact on their nutritional value and health benefits. Here's a closer look at what sets brown rice apart and why it's worth including in your MAKES BROWN RICE DIFFERENTBrown rice is a whole grain that retains its bran and germ layers, which are removed in white rice during polishing. These layers are rich in nutrients, antioxidants, fibre, and essential fatty acids, most of which are lost when rice is refined into white rice. The only part removed in brown rice is the inedible outer husk, allowing the grain to keep its nutritional integrity. NUTRITIONAL COMPARISONBrown rice outshines white rice in several key areasFibre: A cup of cooked brown rice contains about 3.5 grams of fiber, compared to just 0.6 grams in white It provides more magnesium, phosphorus, selenium, and potassium. Vitamins: Higher in B1 (thiamine), B3 (niacin), and B6, which are crucial for energy metabolism and brain The bran layer offers antioxidants and anti-inflammatory compounds not found in white FOR DIGESTIVE AND METABOLIC HEALTHThe fibre in brown rice supports healthy digestion, helps prevent constipation, and promotes overall gut health. Its lower glycemic index means it causes a slower rise in blood sugar, making it suitable for people with diabetes or those looking to stabilise energy levels throughout the and weight benefitsBrown rice has been linked to improved heart health due to its high magnesium and plant lignan content, which support blood pressure regulation and arterial flexibility. It also promotes a feeling of fullness, which can help with weight management by curbing overeating.A good option for gluten-free dietsFor those with gluten intolerance or celiac disease, brown rice is a safe and nutritious carbohydrate source. Its whole-grain status also makes it a more wholesome choice than many processed gluten-free WAYS TO INCLUDE IT IN YOUR MEALSBrown rice can be used in most recipes that call for white rice. Try it in pulao, stir-fries, grain bowls, or even as a base for curry. Cooking it with aromatic spices or vegetable broth can enhance its earthy flavor. Soaking the grains for a few hours before cooking helps reduce cooking time and improve texture. While white rice may be a staple in many Indian households due to taste and tradition, switching to brown rice offers a clear advantage in terms of nutrients and long-term health benefits. Even replacing white rice with brown rice a few times a week can support better digestion, metabolic health, and overall well-being.- Ends
